David Semela

9.7k citations
133 papers · 7.8k · 5 hit papers · h-index 41

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver physiology and pathology
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Diseases and Immunity
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 41
    • Liver Disease and Transplantation 15
    • Hepatocellular Carcinoma Treatment and Prognosis 11
    • Liver physiology and pathology 10
    • Liver Diseases and Immunity 8
    • Liver Disease Diagnosis and Treatment 36
    • Hepatitis B Virus Studies 14

David Semela

127 papers receiving 7.6k citations

David Semela's Hit Papers

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis 2021 · 218 citations
2180+5+11Years since publication2505007501000

Peers

David Semela
Comparison fields: 5 of 130
  • Hepatology 4.1k
  • Epidemiology 3.3k
  • Cancer Research 392
  • Endocrinology, Diabetes and Metabolism 429
  • Pathology and Forensic Medicine 408
Replace Yury V. Popov with:
Yury V. Popov United States
Dominique Wendum France
Yock Young Dan Singapore
Maria Lorena Abate Italy
Kwan Sik Lee South Korea
Holger M. Hinrichsen Germany
Takafumi Ichida Japan
Scott J. Cotler United States
Bertrand Nalpas France
Susanne Beckebaum Germany
David Semela relative to Yury V. Popov United States Yury V. Popov's profile →
Citations per field
00.5×1.5×2.2×
Yury V. Popov · 1×
Citations per year

Countries citing papers authored by David Semela

Since Specialization
Citations

This map shows the geographic impact of David Semela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Semela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Semela more than expected).

Fields of papers citing papers by David Semela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Semela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Semela. The network helps show where David Semela may publish in the future.

Co-authors

The 25 scholars most cited alongside David Semela, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Semela Line = papers co-authored together David Semela links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Hit paper breakdown →
20191063
2
Angiogenesis in liver disease
Hit paper breakdown →
2009508
3
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Hit paper breakdown →
2014415
4
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Hit paper breakdown →
2020363
5 2004314
6 2016290
7 2020229
8 2016218
9
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
Hit paper breakdown →
2021218
10 2014211
11 2007208
12 2019204
13 2007193
14 2016186
15 2014155
16 2017133
17 2012130
18 2008124
19 2001123
20 2007113

About David Semela

David Semela is a scholar working on Hepatology, Epidemiology, Genetics, Surgery and Cancer Research, having authored 133 papers that have together received 7.8k indexed citations. Recurring topics across this work include Hepatitis C virus research (41 papers), Liver Disease Diagnosis and Treatment (36 papers), Liver Disease and Transplantation (15 papers), Hepatitis B Virus Studies (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver physiology and pathology (10 papers), Inflammatory Bowel Disease (10 papers) and Liver Diseases and Immunity (8 papers). The work is most often cited by research in Hepatology (4.1k citations), Epidemiology (3.3k citations), Cancer Research (392 citations), Endocrinology, Diabetes and Metabolism (429 citations) and Pathology and Forensic Medicine (408 citations). David Semela has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Jean‐François Dufour, Vijay H. Shah, Mercedes Fernández, Massimo Pinzani, Jordi Bruix, Jaume Bosch, Isabelle O. Colle, June Sung Lee, John Peter Iredale and Markus Hermann Heim. Their work appears in journals such as Journal of Hepatology, Swiss Medical Weekly, Gastroenterology, Liver International and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact